Navigation Links
New Test Assesses Individual Breast Cancer Risk
Date:10/5/2009

aluated by any pathologist in any town in America."

More information

The American Cancer Society has more on risk factors for breast cancer.



SOURCES: Derek Radisky, Ph.D., assistant professor, biochemistry, Mayo Clinic, Jacksonville, Fla.; Angela Bradbury, M.D., director, Margaret Dyson Family Risk Assessment Program, Fox Chase Cancer Center, Philadelphia; Oct. 5, 2009, Journal of Clinical Oncology, online


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Thomson Healthcare Launches Application That Assesses Physician Performance
2. Bridges to Excellence Study Assesses Clinical and Financial Impact of Physician Quality Measures
3. New method assesses risks for heart failure patients
4. Venables Election Watch Group Assesses Presidential Elections Impact on Multiple Industries
5. Americans United for Life Assesses State Ballot Initiative Outcomes, Predicts Regrouping and Strong Comeback in Next Election Cycle for Life Issues
6. New MedPredict Report Assesses Current Outlook for Anticoagulants Market
7. Study assesses new surgical procedure for regenerating cartilage in damaged knee joints
8. Test quickly assesses whether Alzheimers drugs are hitting their target
9. Panel assesses evidence for the collection and use of family health history information
10. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
11. Precedent Launches Revolutionary Individual Health Insurance Plans in Texas

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009).... 20 Following a recall by Unileve...from sale Shedd,s Country Crock ® Side Dishes...Crock ® Side Dishes DELUXE Four Cheese Pasta ...following code dates and UPCs are affected: ,, ...heddar Broccoli Rice 21 oz, UPC 027400218316, Best...
(Date:11/20/2009)...PRNewswire-USNewswire/ -- The American Dental Asso...dministration (FDA) to establish appropriate class...iting concern about the safety of whitening produc... of professional consultation or examination by a ... of chemically based tooth whitening or bleaching ...
(Date:11/20/2009)...., Nov. 20 Samuel Gladd...ine what it means to be "happy" during the holiday...cialty in family counseling and chair of the Depar...dding says research shows that it is the pressure ...epression during the holidays. ,, That,s why he...
(Date:11/20/2009)...ne November 20 in the Journal of the National Can... hopes that often appear in news coverage of cance...th the media and journals to help alleviate the pr...n Woloshin, M.D., M.S., of Center for Medicine and...olicy and Clinical Practice in New Hampshire, and ...
(Date:11/20/2009)...ber 20, 2009Emergency medical service (EMS) provid...00 cardiac arrests each year. Only 5 to 10 percen.... Better quality cardiopulmonary resuscitation (C...ssociated with better patient outcome. The Resusc...linical research network to study prehospital trea...
Breaking Medicine News(10 mins):Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...xperts at the electromagnetic radiation research c...health risks of low level radiowaves. Radiowaves a...life - what with cellphones,// wireless computers ...r words, we are bathed in an invisible 'electrosmo...
...octors at the University of Texas, offer provide s...my. Even if you are not overweight, you might find...ust have a genetic tendency to accumulate// fat in...ds of sit-ups. All round general exercise is bette...
...ltitude sickness is one of the most common encount...ings into why some mountain climbers are affected ...two changes in a gene related to lung function may...feet. It is a potentially deadly breathing disorde...
...espite the fact that doctors know the power of a c...rt attacks and heart failure, many patients do not...eta-blocker medication after a heart attack// can ...re, do not take the drugs. A new study finds there...
...ctuating heat to destroy cancerous tissue assists ...frequency ablation involves the use of heat to des... has been used to effect in varied tumour types. ...tients were not candidates for standard surgery an...
...ccording to a web-based survey, biting a bar of ch...ppy feelings. Eventhough chocolates are high in fa...e indulgence.// However, recent evidence suggests ...ath, now suggest that people who eat chocolate reg...
Other Medicine News:
(Date:11/20/2009)... Boston Scientific Corpor...eceived 510(k) clearance from the U.S. Food and Dr...rket its WallFlex® Fully Covered Esophageal S...ictures (obstructions) caused by tumors in patient...cer. ,, (Photo: http://www.newscom.com/cgi-b...
(Date:11/20/2009)...tCall/ -- Cyberonics, Inc. (Nasdaq: CYBX ) today ...utive Officer, and Greg Browne, Chief Financial Of...ay Health Care Conference in New York on Wednesday...e session and webcast will be audio only and no fo... host a webcast of the presentation live and by re...
(Date:11/20/2009)...swire-FirstCall/ -- BD (Becton, Dickinson and Comp... of its acquisition of HandyLab, Inc., an Ann Arbo...ctures molecular diagnostic assays and automation ...unced an exclusive agreement for BD to develop and...guar(TM) platform, the first fully integrated mole...
Breaking Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 1Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 2Gentiva 28R 29 Health Services Acquisition Extends Certificate of Need Coverage in West Virginia 50503 3Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo Regeneration 50500 1Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo Regeneration 50500 2Fate Therapeutics Granted Exclusive License By The Regents of the University of California to Stem Cell Modulators for Osteo Regeneration 50500 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 1Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 2Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 3Peregrine Awarded European Patent for Innovative Labeling Technology Featured in New Study in The Journal of Nuclear Medicine 12864 4
...y 8 VION PHARMACEUTICALS,INC. (Nasdaq: VION ) to...ed,Phase I/II clinical trial of its lead anticance...with cytarabine in elderly patients with,previousl...igh-risk,myelodysplastic syndromes (MDS). The tria...K. Ritchie, M.D. at The Weill-Cornell Medical Coll...
...tering Cancer Center Investigators to Assess BSI-2...er Patients -, BRISBANE, Calif., May 8 BiPar Sci... 2 clinical trial programs for its lead,product, B... clinical trial,of BSI-201 that BiPar has launched...s in breast and brain cancer., The company is eva...
Other Medicine Technology:Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 2Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine 3BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer 2
Blue Line® Uncuffed Nasal Endotracheal Tubes (Ivory) Magill
Blue Line® Cuffed Cut-to-Length Oral/Nasal Endotracheal Tubes (clear PVC) Murphy
Uncuffed Nasoral Murphy
Super Safety Magill Cuffed Pediatric ET
Medicine Products: